< Back to previous page

Publication

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT) : a randomised, double-blind, placebo-controlled phase 3 trial

Journal Contribution - Journal Article

Journal: LANCET
ISSN: 1474-547X
Issue: 10139
Volume: 391
Pages: 2503 - 2512
Publication year:2018
BOF-keylabel:yes
IOF-keylabel:yes
BOF-publication weight:10
CSS-citation score:4
Authors:International
Authors from:Higher Education
Accessibility:Closed